• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素对依洛前列素和福斯高林刺激的前列环素结合及血小板腺苷酸环化酶活性的影响。

Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.

作者信息

Jaschonek K, Faul C, Daiss W, Weisenberger H

出版信息

Prostaglandins Leukot Med. 1986 Oct;24(2-3):199-206. doi: 10.1016/0262-1746(86)90127-7.

DOI:10.1016/0262-1746(86)90127-7
PMID:2432618
Abstract

Heparin is known to impair the antiaggregatory effectiveness of prostacyclin (PGI2) for adenosine diphosphate-induced aggregation in citrated platelet rich plasma. Thus porcine mucosal heparin (PMH) from different commercial sources was investigated for its ability to compete with specific platelet prostacyclin binding. In concentrations up to 250 IU/ml PMH itself did not interfere with the binding of 3 X 10(-9) M 9-3H-PGI2-sodium salt to intact washed platelets. The displacement of specifically bound PGI2 observed by PMH (Ki 60 IU/ml) containing 4-chloro-m-cresol (4-CC) was caused by the preservative (Ki 4-CC 3.0 X 10(-4) M). Although 60 IU/ml PMH (free of 4-CC) have been shown to inhibit basal 3 X 10(-5) M forskolin-, and 10(-8)M Iloprost-stimulated adenylate cyclase in platelet membranes (-63%, -62%, -83% respectively), no effect of PMH on 3H-cyclic-AMP formation has been observed when intact platelets were studied by 3H-adenine prelabeling technique. There is also no evidence that the preincubation of PGI2 (5 X 10(-7) M) with 1000 IU/ml PMH might neutralize the effectiveness of this eicosanoid. In contrast, PGI2 preincubated with PMH (10 min, 37 degrees C) caused a more pronounced increase of platelet 3H-cyclic AMP (+65%) compared with PGI2 incubated in 5 X 10(-2) M Tris-HCl, pH 7.4. Thus our data provide no evidence that PMH interferes with i) specific platelet PGI2 binding, ii) PGI2-stimulated cyclic AMP synthesis or iii) neutralizes PGI2 by formation of a biologically less active PGI2-PMH complex.

摘要

已知肝素会损害前列环素(PGI2)对枸橼酸化富血小板血浆中由二磷酸腺苷诱导的聚集的抗聚集效力。因此,对来自不同商业来源的猪黏膜肝素(PMH)与特异性血小板前列环素结合的竞争能力进行了研究。浓度高达250 IU/ml时,PMH本身并不干扰3×10⁻⁹ M 9-³H-PGI2钠盐与完整洗涤血小板的结合。含有4-氯间甲酚(4-CC)的PMH(Ki 60 IU/ml)观察到的特异性结合PGI2的置换是由防腐剂(Ki 4-CC 3.0×10⁻⁴ M)引起的。尽管已证明60 IU/ml PMH(不含4-CC)可抑制血小板膜中基础3×10⁻⁵ M福司可林、10⁻⁸ M伊洛前列素刺激的腺苷酸环化酶(分别为-63%、-62%、-83%),但在用³H-腺嘌呤预标记技术研究完整血小板时,未观察到PMH对³H-环磷酸腺苷形成的影响。也没有证据表明PGI2(5×10⁻⁷ M)与1000 IU/ml PMH预孵育可能会中和这种类花生酸的效力。相反,与在5×10⁻² M Tris-HCl,pH 7.4中孵育的PGI2相比,与PMH预孵育(10分钟,37℃)的PGI2导致血小板³H-环磷酸腺苷更明显的增加(+65%)。因此,我们的数据没有提供证据表明PMH会干扰:i)特异性血小板PGI2结合;ii)PGI2刺激的环磷酸腺苷合成;iii)通过形成生物活性较低的PGI2-PMH复合物来中和PGI2。

相似文献

1
Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.肝素对依洛前列素和福斯高林刺激的前列环素结合及血小板腺苷酸环化酶活性的影响。
Prostaglandins Leukot Med. 1986 Oct;24(2-3):199-206. doi: 10.1016/0262-1746(86)90127-7.
2
Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase.血小板对伊洛前列素的脱敏作用。特异性结合位点的丧失及腺苷酸环化酶的异源脱敏作用。
Eur J Pharmacol. 1988 Mar 1;147(2):187-96. doi: 10.1016/0014-2999(88)90777-7.
3
Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.功能和配体结合研究表明血小板前列环素受体存在异质性。
Br J Pharmacol. 1989 Jul;97(3):657-68. doi: 10.1111/j.1476-5381.1989.tb12001.x.
4
Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.奥替米贝特是一种有效的非前列腺素类血小板聚集抑制剂,通过前列环素受体发挥作用。
Br J Pharmacol. 1991 Jan;102(1):251-9. doi: 10.1111/j.1476-5381.1991.tb12162.x.
5
Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.既是血栓素受体拮抗剂又是前列环素模拟物的前列腺素内过氧化物类似物。
Br J Pharmacol. 1986 Mar;87(3):543-51. doi: 10.1111/j.1476-5381.1986.tb10196.x.
6
Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil.
Thromb Res. 1986 May 15;42(4):477-87. doi: 10.1016/0049-3848(86)90211-2.
7
Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.腺苷酸环化酶激活剂与一氧化氮供体SIN-1对血小板环磷酸腺苷的协同相互作用。
Eur J Pharmacol. 1995 May 26;289(3):455-61. doi: 10.1016/0922-4106(95)90154-x.
8
Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia.
Biochem Pharmacol. 1983 Jul 1;32(13):1989-93. doi: 10.1016/0006-2952(83)90416-1.
9
Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.依洛前列素、前列环素和前列腺素E1等摩尔浓度对人血小板功能的比较。
J Lab Clin Med. 1987 Feb;109(2):184-90.
10
The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.使用稳定前列腺素研究人血小板膜中前列环素(PGI2)结合位点和PGI2敏感腺苷酸环化酶。
Prostaglandins. 1984 Feb;27(2):321-33. doi: 10.1016/0090-6980(84)90083-2.